托皮拉酸会加剧肝损伤:关于NAFLD,化应激和亡的研究
Sevtap Kılınç1, Pelin Şahin2, Zeynep Yığman3,4
1Department of Physiology, Başkent University, Faculty of Medicine, Ankara, Turkey.
托皮拉酸盐 (TPM) 增加肝脏的化应激和亡,即使在健康的肝脏中也是如此. 这种抗肥胖药物在患有非酒精性脂肪性肝病 (NAFLD) 的肥胖个体中需要仔细评估.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 经常与肥胖同时发生.
- 托皮拉 (TPM) 是一种具有已知的肝氧化作用的抗肥胖药物.
- 在NAFLD中,TPM对化应激,炎症和亡的影响仍未得到充分研究.
研究的目的:
- 在非酒精性脂肪性肝病 (NAFLD) 的老鼠模型中研究托皮拉 (TPM) 对化应激,炎症和亡的影响.
- 为了确定TPM是否会在NAFLD存在时加剧肝损伤.
主要方法:
- 在6周的高脂肪饮食中,雄性Wistar白色老鼠被诱导患有NAFLD.
- 组接受了对照饮食,高脂肪饮食,TPM (100 mg/kg/d),或高脂肪饮食加TPM21天.
- 对肝脏组织进行了分析,以检测化应激 (NO,甲酸),炎症 (TNF-α,IL-10) 和亡 (caspase-3,caspase-9,cytochrome-c,BAX,BCL-2) 的标志物.
主要成果:
- 在标准饮食和高脂肪饮食组中,TPM的使用增加了氧化 (NO) 和酸铁的水平,表明了酸性压力.
- TPM和高脂肪饮食独立地增加了亡标志物 (酶-3,酶-9,细胞染色体-c). 同时使用进一步提高了caspase-9和cytochrome-c的水平.
- 在高脂肪饮食和TPM组组合中,瘤缩因子-α (TNF-α) 水平显著升高,表明炎症恶化.
结论:
- 托皮拉 (TPM) 诱导肝脏化应激和亡,独立于非酒精性脂肪性肝病 (NAFLD) 状态.
- 与高脂肪饮食同时服用TPM会加剧肝损伤的某些标志物,包括亡和炎症.
- 这些发现强调了需要仔细临床评估TPM作为抗肥胖剂的必要性,特别是在NAFLD患者中.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Antiepileptic Drugs: Glutamate Antagonists
Phase I Reactions: Reductive Reactions
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
